Executive Board

Christopher Murphy

Dr. Murphy is a founder, serves as CEO, and provides consulting in veterinary ophthalmology.

Dr. Murphy is a Board Certified Veterinary Ophthalmologist, and Professor of Comparative Ophthalmology in the Schools of Veterinary Medicine & Medicine, University of California-Davis. Dr. Murphy has advanced training and expertise in corneal diseases and surgery, comparative physiological optics, comparative ocular anatomy, as well as ocular diseases of laboratory and exotic animal species.

His laboratory has several active areas of research:

T. Michael Nork

Dr. Nork is a founder, serves as a member of the Executive Board, and provides consulting on many aspects of vision science.

Dr. Nork is an Associate Professor of Ophthalmology at the University of Wisconsin School of Medicine and Public Health. He is fellowship trained in ophthalmic pathology, and his clinical specialties include diseases, surgery of the retina and vitreous, and clinical electrophysiology.

Charles O'Neill

Dr. O'Neill serves as a member of the Executive Board and provides consulting on many aspects of vision science with a specific focus on study design and regulatory requirement considerations for IND submission.  Dr. O'Neill is an Assistant Adjunct Professor in the Pharmacology and Toxicology Graduate Group at University of California-Davis. He has contributed to 26 regulatory submissions in the US, EU, Australia and Japan, coauthored over 40 peer-reviewed publications, and been a Diplomate of the American Board of Toxicology since 1995.

Gary Leatherberry

Our administrative team includes specialists who have direct experience working both in research and industry settings. Together, they have the knowledge and skills necessary to manage day-to-day activities, facilitate partnerships, and build an increasingly effective research-industry operation.

Craig Crosson

Dr. Crosson serves as a member of the Executive Board and provides consulting on many aspects of vision science with a specific focus on pharmacology and animal models of elevated intraocular pressure, retinal degenerations and macular edema.  Dr. Crosson is a Professor in the Department of Ophthalmology at the Medical University of South Carolina (MUSC). He is also Director of the Ola B. Williams Glaucoma Therapeutic Development Center and Senior Associate Dean for Research at MUSC. His research interests include ischemia, neovascularization, and neuroprotection.